[1] Abbasi, F., Reaven, G.M., 2002. Relationship between fasting and day-long plasma glucose concentrations in diet-treated patients with type 2 diabetes. Metabolism, 51(4):457-459.

[2] Bonora, E., Calcaterra, F., Muggeo, M., 2001. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care, 24:2023-2029.

[3] Crawford, L.M., Sinha, R.N., Odell, R.M., Comi, R.J., 2000. Efficacy of insulin pump therapy: mealtime delivery is the key factor. Endocr. Pract., 6(3):239-243.

[4] Knee, T.S., Seidensticker, D.F., Walton, J.L., Solberg, L.M., Lasseter, D.H., 2003. A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series. Endocr. Pract., 9(3):181-186.

[5] Monnier, L., Lapinski, H., Colette, C., 2003. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care, 26(3):881-885.

[6] Zinman, B., 2000. Basal insulin replacement and use of rapid-acting insulin analogues in patients with type 1 diabetes. Endocr. Pract., 6(1):88-92.